These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8486718)

  • 1. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
    Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
    J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis.
    Iordanov MS; Ryabinina OP; Wong J; Dinh TH; Newton DL; Rybak SM; Magun BE
    Cancer Res; 2000 Apr; 60(7):1983-94. PubMed ID: 10766189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of an antitumor ribonuclease to Purkinje neurons.
    Newton DL; Walbridge S; Mikulski SM; Ardelt W; Shogen K; Ackerman SJ; Rybak SM; Youle RJ
    J Neurosci; 1994 Feb; 14(2):538-44. PubMed ID: 8301353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ribonuclease A variant with low catalytic activity but high cytotoxicity.
    Bretscher LE; Abel RL; Raines RT
    J Biol Chem; 2000 Apr; 275(14):9893-6. PubMed ID: 10744660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.
    Newton DL; Boque L; Wlodawer A; Huang CY; Rybak SM
    Biochemistry; 1998 Apr; 37(15):5173-83. PubMed ID: 9548748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the intracellular routing of cytotoxic ribonucleases.
    Wu Y; Saxena SK; Ardelt W; Gadina M; Mikulski SM; De Lorenzo C; D'Alessio G; Youle RJ
    J Biol Chem; 1995 Jul; 270(29):17476-81. PubMed ID: 7542240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase.
    Lee I; Lee YH; Mikulski SM; Lee J; Shogen K
    Anticancer Res; 2000; 20(2A):1037-40. PubMed ID: 10810394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNase inhibition of human immunodeficiency virus infection of H9 cells.
    Youle RJ; Wu YN; Mikulski SM; Shogen K; Hamilton RS; Newton D; D'Alessio G; Gravell M
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6012-6. PubMed ID: 8016107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.
    Lin JJ; Newton DL; Mikulski SM; Kung HF; Youle RJ; Rybak SM
    Biochem Biophys Res Commun; 1994 Oct; 204(1):156-62. PubMed ID: 7945354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational stability is a determinant of ribonuclease A cytotoxicity.
    Klink TA; Raines RT
    J Biol Chem; 2000 Jun; 275(23):17463-7. PubMed ID: 10747991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.
    Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM
    Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
    Ardelt W; Shogen K; Darzynkiewicz Z
    Curr Pharm Biotechnol; 2008 Jun; 9(3):215-25. PubMed ID: 18673287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective expression of ribonuclease-onconase in Escherichia coli and assaying its cytotoxic potential].
    Xu GF; Wang QC; Gong XG; Fei J
    Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):227-31. PubMed ID: 15323425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor.
    Mikulski SM; Viera A; Deptala A; Darzynkiewicz Z
    Int J Oncol; 1998 Oct; 13(4):633-44. PubMed ID: 9735389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 production and selective degradation of viral RNA by an amphibian ribonuclease.
    Saxena SK; Gravell M; Wu YN; Mikulski SM; Shogen K; Ardelt W; Youle RJ
    J Biol Chem; 1996 Aug; 271(34):20783-8. PubMed ID: 8702832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endowing human pancreatic ribonuclease with toxicity for cancer cells.
    Leland PA; Staniszewski KE; Kim BM; Raines RT
    J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases.
    Smith MR; Newton DL; Mikulski SM; Rybak SM
    Exp Cell Res; 1999 Feb; 247(1):220-32. PubMed ID: 10047464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribonuclease A variants with potent cytotoxic activity.
    Leland PA; Schultz LW; Kim BM; Raines RT
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10407-12. PubMed ID: 9724716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.